ASHPOfficial

In this podcast, we will discuss how artificial intelligence machine learning, data science and analytics are being incorporated into pharmacy education and how pharmacists can be better prepared to enter the ever-changing workforce. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tom and Jillanne will cover a recent communication from Medicaid to the states, directing them to allow providers authorized under the PREP Act to order and administer vaccines to enroll in Medicaid. We’ll discuss what this tone shift signals for pharmacists and how it intersects with broader provider status efforts.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The first of many new and emerging long-acting antiretroviral therapy (LA ART) regimens recently received FDA approval for the treatment and prevention of HIV infection. The panel discusses LA ART and its impact on clinical practice. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Residency program directors (RPD) from across the country will discuss successful personal and health system resiliency strategies across the spectrum for supporting individual well-being and cultivating organizational cultures committed to mitigating occupational burnout. Content will include members sharing experiences related to individual and organizational resiliency, implementation of solutions, and strategies for self-care.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Listen to our Advocacy Roundtable Discussion with ASHP’s government relations team regarding our top advocacy priorities. This discussion with Tom Kraus, vice president of government relations, Jillanne Schulte Wall, senior director of Health and Regulatory Policy, and Kyle Robb, director of state policy advocacy, provides ASHP members with an inside look at federal advocacy topics impacting the practice of pharmacy. Topics discussed include pharmacist provider status, 340B, elimination of the X-waiver for buprenorphine prescribing, white bagging, and more.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

This podcast episode discusses strategies to ensure pharmacy technicians have a voice in pharmacy, associated committees, and outcomes. With the heightened national issue around the pharmacy technician workforce the conversation shares how these processes impacts professional satisfaction, engagement, and retention for pharmacy technicians.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The ASHP Practice Advancement Initiative (PAI) 2030 provides aspiration guidance and is intended to propel changes in pharmacy practice that will have a major impact on the responsible use of medicines. Student Societies of Health-System Pharmacists (SSHPs) are actively promoting the pillars of PAI 2030 within their chapters. In this podcast episode, we will highlight examples of how to incorporate PAI into SSHP initiatives.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this podcast, listeners learn about establishing a professional identify as a new practitioner. Speakers include new practitioner members ranging from new graduates to practitioners with a few years of experience. Speakers share their insight and advice on crafting a professional identity and how that identity can evolve throughout your training and career. For additional resources related to establishing a professional identity, check out the ASHP Professional Identify Formation Worksheet, developed by members of the New Practitioners Forum. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago. 

ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV. and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction. Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Please join us for an introduction to pharmacists career ladders, including their impact and benefits. This session will outline a pharmacist career ladder while providing insight into barriers and strategies for success with implementation.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.